Graves' Disease News and Research

RSS
Graves’ disease, also known as toxic diffuse goiter, is the most common cause of hyperthyroidism in the United States. Hyperthyroidism is a disorder that occurs when the thyroid gland makes more thyroid hormone than the body needs.
Pediatric patients undergoing thyroid surgery have better outcomes at high-volume centers

Pediatric patients undergoing thyroid surgery have better outcomes at high-volume centers

Study shows how some autoimmune diseases are more closely related than others

Study shows how some autoimmune diseases are more closely related than others

AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute

AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

IBS scientists uncover biological pathway that contributes to thyroid disorder

IBS scientists uncover biological pathway that contributes to thyroid disorder

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

New ATA recommendations offer guidance for managing all forms of thyrotoxicosis

New ATA recommendations offer guidance for managing all forms of thyrotoxicosis

Scientists discover underlying mechanisms of proptosis in patients with thyroid eye disease

Scientists discover underlying mechanisms of proptosis in patients with thyroid eye disease

Study reveals demographic and clinical disparities associated with substernal thyroid goiters

Study reveals demographic and clinical disparities associated with substernal thyroid goiters

Finding may aid in the design of potential therapies for thyroid problems

Finding may aid in the design of potential therapies for thyroid problems

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Endocrine Society selects 18 endocrinologists as winners of 2016 Laureate Awards

Endocrine Society selects 18 endocrinologists as winners of 2016 Laureate Awards

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Apitope's ATX-F8-117 granted orphan medicinal product designation for treatment of haemophilia A

Apitope's ATX-F8-117 granted orphan medicinal product designation for treatment of haemophilia A

New research findings on Graves' disease to be highlighted at ATA meeting

New research findings on Graves' disease to be highlighted at ATA meeting

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Scientists make important breakthrough in fight against debilitating autoimmune diseases

Scientists make important breakthrough in fight against debilitating autoimmune diseases

Ophthalmologist recommends alternative therapy for Graves' eye disease

Ophthalmologist recommends alternative therapy for Graves' eye disease